ArticleOncoTargets and therapy2015

The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myeloma.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.